Dose-dependent effects of PSC 833 on its tissue distribution and on the biliary excretion of endogenous substrates in rats

Drug Metabolism and Disposition

Volumn 26, Issue 11, 1998, Pages 1128-1133

  Song, Saeheum ^b   Suzuki, Hiroshi ^b   Kawai, Ryosei ^b   Tanaka, Chiaki ^b   Akasaka, Izumi ^b   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYCOPROTEIN P; TRITIUM; VALSPODAR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILIARY EXCRETION; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG ELIMINATION; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; DRUG UPTAKE; FEMALE; INTESTINE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; RAT; SPLEEN; TISSUE DISTRIBUTION; URINARY EXCRETION;

ANIMALS; AREA UNDER CURVE; BILE; BILE ACIDS AND SALTS; BILIARY TRACT; CYCLOSPORINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUTATHIONE; HALF-LIFE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

ANIMALIA; TRITIUM;

EID: 0031738505     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Adams JD, Lauterburg BH and Michel JR (1983) Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther 227:749-754.
2. Archinal-Mattheis A, Rzepka RW, Watanabe T, Kokubu N, Itoh Y, Combates NJ, Bair KW and Cohen D (1995) Analysis of the interactions of SDZ PSC 833 ([3′-keto-Bmt1]-Va12]-cyclosporine), a multidrug resistance modulator, with P-glycoprotein. Oncol Res 7:603-610.
3. Böhme M, Büchler M, Müller M and Keppler D (1993) Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS Lett 333:193-196.
4. Böhme M, Müller M, Leier I, Jedlitschky G and Keppler D (1994) Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology 107:255-265.
5. Boote DJ, Dennis IF, Twentyman PR, Osborne RJ, Laburte C, Hensel S, Smyth JF, Brampton MH and Bleehen NM (1996) Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer. J Clin Oncol 14:610-618.
6. Büchler M, Konig J, Brom M, Kartenbeck J, Spring H, Horie T and Keppler D (1996) cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 271:15091-15098.
7. de Lannoy IA, Mandin RS and Silverman M (1994) Renal secretion of vinblastine, vincristine and colchicine in vivo. J Pharmacol Exp Ther 268:388-395.
8. Eberle D, Clarke R and Kaplowitz N (1981) Rapid oxidation in vitro of endogenous and exogenous glutathione in bile of rats. J Biol Chem 256:2115-2117.
9. Erlinger S (1996) New insights into the mechanisms of hepatic transport and bile secretion. J Gastroenterol Hepatol 11:575-579.
10. Fernandez-Checa JC, Takikawa H, Horie T, Ookhtens M and Kaplowitz N (1992) Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats. J Biol Chem 267:1667-1673.
11. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T and Sugiyama Y (1996) Expression of a putative ATP binding cassette region, homologous to that in multidrug resistance associated protein (MRP), is hereditarily defective in Eisai hyperbilirubinemic rats (EHBR). Int Hepatol Commun 4:291-298.
12. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T and Sugiyama Y (1997) Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol 272:G16-G22.
13. Keller RP, Altermatt HJ, Nooter K, Poschman G, Laissue JA, Bollinger P and Hiestand PC (1992) SDZ PSC 833, a nonimmunosuppressive cyclosporin: its potency in overcoming P-glycoprotein mediated multidrug resistance of murine leukemia. Int J Cancer 50:593-597.
14. Kivisto KT, Kroemer HK and Eichelbaum M (1995) The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br J Clin Pharmacol 40:523-530.
15. Kusuhara H, Suzuki H, Terasaki T, Kakee A, Lemaire M and Sugiyama Y (1997) P-glycoprotein mediates the efflux of quinidine across the blood-brain barrier. J Pharmacol Exp Ther 283:574-580.
16. Lemaire M, Bruelisauer A, Guntz P and Sato H (1996) Dose-dependent brain penetration of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin, in rats. Cancer Chemother Pharmacol 38:481-486.
17. Li G, Treiber G, Meinshausen J, Wolf J, Werringloer J and Klotz U (1990) Is cyclosporin A an inhibitor of drug metabolism? Br J Clin Pharmacol 30:71-77.
18. Lum BL, Fisher GA, Brophy NA, Yahanda AM, Adler KM, Kaubisch S, Halsey J and Sikic BI (1993) Clinical trials of modulation of multidrug resistance: pharmacokinetic and pharmacodynamic considerations. Cancer 72(Suppl):3502-3514.
19. Lush RM, Meadows B, Fojo AT, Kalafsky G, Smith HT, Bates S and Figg WD (1997) Initial pharmacokinetics and bioavailability of PSC 833, a P-glycoprotein antagonist. J Clin Pharmacol 37:123-128.
20. Mashige F, Tanaka N, Maki A, Kamei S and Yamanaka M (1981) Direct spectrophotometry of total bile acids in serum. Clin Chem 27:1352-1356.
21. Naito M, Watanabe T, Tsuge H, Koyama T, Oh-Hara T and Tsuruo T (1996) Potentiation of the reversal activity of SDZ PSC 833 on multi-drug resistance by an anti-P-glycoprotein monoclonal antibody, MRK-16. Int J Cancer 67:435-440.
22. Oude Elferink RP, Meijer DK, Kuipers F, Jansen PL, Groen AK and Groothuis GM (1995) Hepatobiliary secretion of organic compounds: molecular mechanisms of membrane transport. Biochim Biophys Acta 1241:215-268.
23. Paulusma CC, Bosma PJ, Zaman GJ, Bakker CT, Otter M, Scheffer GL, Scheper RJ, Borst P and Oude Elferink RP (1996) Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science (Washington DC) 271:1126-1128.
24. Speeg KV and Maldonado AL (1994) Effect of the nonimmunosuppressive cyclosporin analog SDZ PSC 833 on colchicine and doxorubicin biliary secretion by the rat in vivo. Cancer Chemother Pharmacol 34:133-136.
25. Tietze F (1969) Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 27:502-522.
26. Toffoli G, Corona G, Sorio R, Bertola A and Boiocchi M (1997) Reversal activity of cyclosporin A and its metabolites M1, M17 and M21 in multidrug-resistant cells. Int J Cancer 71:900-906.
27. Wacher VJ, Wu CY and Benet LZ (1995) Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 13:129-134.
28. Wagner O, Schreier E, Heitz F and Maurer G (1987) Tissue distribution, disposition, and metabolism of cyclosporine in rats. Drug Metab Dispos 15:377-383.
29. Watanabe T, Miyauchi S, Sawada Y, Iga T, Hanano M, Inaba M and Sugiyama Y (1992) Kinetic analysis of hepatobiliary transport of VCR in perfused rat liver: possible roles of P-glycoprotein in biliary excretion of vincristine. J Hepatol 16:77-88.
30. Watanabe T, Suzuki H, Sawada Y, Naito M, Tsuruo T, Inaba M, Hanano M and Sugiyama Y (1995a) Induction of hepatic P-glycoprotein enhances biliary excretion of vincristine in rats. J Hepatol 23:440-448.
31. Watanabe T, Tsuge H, Oh-Hara T, Naito M and Tsuruo T (1995b) Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo. Acta Oncol 34:235-241.
32. Yamazaki M, Suzuki H and Sugiyama Y (1996) Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. Pharm Res 13:497-513.